Incyte Logo Preview
Learn more about the Incyte brand, find out the Incyte colors, and download a Incyte vector logo in the SVG file format.
Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware. The company was founded in Palo Alto, California in 1991 and went public in 1993. Incyte has one drug, Jakafi, which has been approved by the U.S. Food and Drug Administration and has been prescribed to patients in the United States. As of 2014, the company was developing baricitinib, an oral JAK1 and JAK2 inhibitor drug for rheumatoid arthritis in partnership with Eli Lilly. It gained EU approval in February 2017. In April 2017, the US FDA issued a rejection, citing concerns about dosing and safety. As of 2016 epacadostat, an indoleamine 2,3-dioxygenase inhibitor, was in development for various cancers and was in combination trials with Merck’s pembrolizumab and Bristol Myers Squibb’s nivolumab. In 2013, Novartis acquired Incyte’s c-Met inhibitor capmatinib.